Kinnari Patel - President, Head of R&D and Chief Operating Officer at ROCKET PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type: Individual
Role: President, Head of R&D and Chief Operating Officer
Issuer Symbol: RCKT, RCKTW on Nasdaq
All Insider Reports: All Insider Reports

Kinnari Patel - trading volume in the past year for ROCKET PHARMACEUTICALS, INC.

	Shares	%	Avg Price	Total $
Buys	+21,099	72%	$4.70	+$99,165
Sells	-8,254	28%	$9.50	-$78,447
Net	+12,845	44%		+$20,718

Holdings reported by Kinnari Patel for ROCKET PHARMACEUTICALS, INC.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	441,927	$2,848,661	$6.45	20 May 2025	Direct
Stock Option (Right to Buy)	172,214	$2,590,099	$15.04	11 Feb 2025	Direct	Common Stock
Common Stock	104,927	$779,607	$7.43	20 May 2025	By Adaptive Technology LLC
Common Stock	26,774	$198,930	$7.43	20 May 2025	By Spouse

Transactions reported by Kinnari Patel for ROCKET PHARMACEUTICALS, INC.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.